ShockWave Medical, Inc. (SWAV) Financials

NASDAQ:SWAV

Market Cap

7.69B

Total Revenue

489.73M

Gross Profit

424.74M

Operating Income

124.13M

Net Income

216.00M

Metric	2017	2018	2019	2020	2021	2022
revenue	1,719,000	12,263,000	42,927,000	67,789,000	237,146,000	489,733,000
costOfRevenue	2,836,000	7,250,000	17,159,000	20,991,000	41,438,000	64,996,000
grossProfit	-1,117,000	5,013,000	25,768,000	46,798,000	195,708,000	424,737,000
researchAndDevelopmentExpenses	17,963,000	22,698,000	32,853,000	36,926,000	50,544,000	81,679,000
sellingAndMarketingExpenses	6,363,000	17,536,000	30,620,000	51,672,000	111,288,000	161,995,000
generalAndAdministrativeExpenses	5,422,000	5,979,000	14,134,000	23,863,000	34,747,000	56,929,000
sellingGeneralAndAdministrativeExpenses	11,785,000	23,515,000	44,754,000	75,535,000	146,035,000	218,924,000
operatingExpenses	29,748,000	46,213,000	77,607,000	112,461,000	196,579,000	300,603,000
operatingIncome	-30,865,000	-41,200,000	-51,839,000	-65,663,000	-871,000	124,134,000
totalOtherIncomeExpensesNet	334,000	537,000	792,000	44,000	-7,964,000	-3,306,000
ebitda	-30,031,000	-39,911,000	-49,494,000	-64,407,000	-7,739,000	122,714,000
depreciationAndAmortization	468,000	700,000	2,345,000	1,256,000	-6,868,000	-1,420,000
interestIncome	--	--	--	--	--	--
interestExpense	58,000	401,000	944,000	1,212,000	1,096,000	1,886,000
incomeBeforeTax	-30,589,000	-41,064,000	-51,047,000	-65,619,000	-8,835,000	120,828,000
incomeTaxExpense	26,000	38,000	62,000	80,000	301,000	-95,168,000
netIncome	-30,615,000	-41,102,000	-51,109,000	-65,699,000	-9,136,000	215,996,000
eps	-1.57	-1.53	-2.14	-1.99	-0.26	6.02
epsdiluted	-1.57	-1.53	-2.14	-1.99	-0.26	5.7
weightedAverageShsOut	19,528,258	26,906,762	23,904,828	33,088,095	35,098,130	35,900,738
weightedAverageShsOutDil	19,528,258	26,906,762	23,904,828	33,088,095	35,098,130	37,881,590
costAndExpenses	32,584,000	53,463,000	94,766,000	133,452,000	238,017,000	365,599,000
otherExpenses	366,000	589,000	2,345,000	1,256,000	-582,000	1,055,000

Key Facts

Industry

Medical Devices

Sector

Healthcare

Headquarters

Santa Clara, CA, US

Website

shockwavemedical.com

CEO

Mr. Douglas E. Godshall M.B.A.

Employees

1001

About the Company

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.